Literature DB >> 34936936

Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome.

Thiruchelvi Pulingam1, Thaigarajan Parumasivam2, Amirah Mohd Gazzali2, Azlinah Mohd Sulaiman1, Jiun Yee Chee1, Manoj Lakshmanan3, Chai Fung Chin1, Kumar Sudesh4.   

Abstract

Antibiotic resistance is a major health concern globally and has been estimated to cause 10 million deaths worldwide by year 2050 if the current trend of inappropriate and excessive use of antibiotics continues. Although, the discovery of antibiotics has saved countless of lives for the past 80 years, increasing levels of bacterial resistance to antibiotics would jeopardize the progress in clinical and agricultural sectors and may cause life-threatening situations even for previously treatable bacterial infections. Antibiotic resistance would increase the levels of poverty of low-middle income countries mostly due to extended hospital stays, higher cost of treatment and untimely deaths that directly affect the total productivity rate. Recent incidences of antibiotic resistance have been gradually increasing globally and this may potentiate horizontal transmission of the resistant gene and have been linked with cross-resistance to other antibiotic families as well. This review summarizes the global burden of antibiotic resistance from the economic viewpoint, highlights the recent incidences of antibiotic resistance mainly related to Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Salmonella spp. and Staphylococcus aureus, describes the common mechanistic actions of antibiotic resistance and potential strategies to overcome antibiotic resistance.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotic alternatives; Antibiotic resistance; Antimicrobial resistance; Economic burden; Incidences of cases; Mechanisms of antibiotic resistance

Mesh:

Substances:

Year:  2021        PMID: 34936936     DOI: 10.1016/j.ejps.2021.106103

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

1.  Chia (Salvia hispanica L.) Seeds Contain a Highly Stable Trypsin Inhibitor with Potential for Bacterial Management Alone or in Drug Combination Therapy with Oxacillin.

Authors:  Adson Ávila de Souza; Adrianne Maia Lima; Daniele Dede Oliveira BezerraSousa; Francisca Cristiane Nogueira; José Carlos do Sacramento Neto; Lucas Pinheiro Dias; Nadine Monteiro Salgueiro Araújo; Celso Shiniti Nagano; Hélio Vitoriano Nobre Júnior; Cecília Rocha da Silva; Lívia Gurgel do Amaral Valente Sá; João Batista de Andrade Neto; Fátima Daiana Dias Barroso; Maria Elisabete Amaral de Moraes; Hermógenes David de Oliveira
Journal:  Probiotics Antimicrob Proteins       Date:  2022-08-22       Impact factor: 5.265

2.  Identification of antigens recognized by salivary IgA using microbial protein microarrays.

Authors:  Koji Hamuro; Hiroshi Saito; Takao Saito; Noriyuki Kohda
Journal:  Biosci Microbiota Food Health       Date:  2022-06-06

Review 3.  Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases.

Authors:  Karla Cristina P Cruz; Laura O Enekegho; David T Stuart
Journal:  Front Bioeng Biotechnol       Date:  2022-05-17

4.  Submarine Outfalls of Treated Wastewater Effluents are Sources of Extensively- and Multidrug-Resistant KPC- and OXA-48-Producing Enterobacteriaceae in Coastal Marine Environment.

Authors:  Marija Kvesić; Ivica Šamanić; Anita Novak; Željana Fredotović; Mia Dželalija; Juraj Kamenjarin; Ivana Goić Barišić; Marija Tonkić; Ana Maravić
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 5.640

5.  Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology.

Authors:  Nicola Cuscino; Ayesha Fatima; Vincenzo Di Pilato; Matteo Bulati; Caterina Alfano; Elisa Monaca; Giuseppina Di Mento; Daniele Di Carlo; Francesca Cardinale; Francesco Monaco; Gian Maria Rossolini; Asif M Khan; Pier Giulio Conaldi; Bruno Douradinha
Journal:  Comput Struct Biotechnol J       Date:  2022-08-17       Impact factor: 6.155

6.  Report of a Fatal Purulent Pericarditis Case Caused by ST11-K64 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae.

Authors:  Shiwei Liang; Huijun Cao; Fei Ying; Chenchen Zhang
Journal:  Infect Drug Resist       Date:  2022-08-22       Impact factor: 4.177

7.  Synthesis of the cyanobacterial halometabolite Chlorosphaerolactylate B and demonstration of its antimicrobial effect in vitro and in vivo.

Authors:  Nikoline Jensen; Henrik Elvang Jensen; Bent Aalbaek; Sophie Amalie Blirup-Plum; Sara M Soto; Virginio Cepas; Yuly López; Yaiza Gabasa; Ignacio Gutiérrez-Del-Río; Claudio J Villar; Felipe Lombó; María José Iglesias; Raquel Soengas; Fernando López Ortiz; Louise Kruse Jensen
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

8.  Evaluation of ellagic acid and gallic acid as efflux pump inhibitors in strains of Staphylococcus aureus.

Authors:  Nair Silva Macêdo; Cristina Rodrigues Dos Santos Barbosa; Antonio Henrique Bezerra; Zildene de Sousa Silveira; Larissa da Silva; Henrique Douglas Melo Coutinho; Saeid Dashti; Bonglee Kim; Francisco Assis Bezerra da Cunha; Marcia Vanusa da Silva
Journal:  Biol Open       Date:  2022-10-07       Impact factor: 2.643

9.  Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors.

Authors:  Ilaria D'Agostino; Githa Elizabeth Mathew; Paola Angelini; Roberto Venanzoni; Giancarlo Angeles Flores; Andrea Angeli; Simone Carradori; Beatrice Marinacci; Luigi Menghini; Mohamed A Abdelgawad; Mohammed M Ghoneim; Bijo Mathew; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.